Abstract
This review covers the functionalization of 4,7-dihydroindole derivatives as synthetic equivalents (synthons) for 2-substituted indoles.
Keywords: 4, 7-Dihydroindole, 2-substituted indoles, asymmetric synthesis, conjugate addition, Friedel-Crafts alkylation.
Graphical Abstract
Current Organic Synthesis
Title:4,7-Dihydroindole: A Synthon for the Preparations of 2-Substituted Indoles
Volume: 11 Issue: 2
Author(s): Haydar Kilic, Sinan Bayindir and Nurullah Saracoglu
Affiliation:
Keywords: 4, 7-Dihydroindole, 2-substituted indoles, asymmetric synthesis, conjugate addition, Friedel-Crafts alkylation.
Abstract: This review covers the functionalization of 4,7-dihydroindole derivatives as synthetic equivalents (synthons) for 2-substituted indoles.
Export Options
About this article
Cite this article as:
Kilic Haydar, Bayindir Sinan and Saracoglu Nurullah, 4,7-Dihydroindole: A Synthon for the Preparations of 2-Substituted Indoles, Current Organic Synthesis 2014; 11 (2) . https://dx.doi.org/10.2174/1570179411999140304102909
DOI https://dx.doi.org/10.2174/1570179411999140304102909 |
Print ISSN 1570-1794 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6271 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Potentials of Polymeric Nanoparticle as Drug Carrier for Cancer Therapy: With a Special Reference to Pharmacokinetic Parameters
Current Drug Metabolism ANTI-ADHESION Evolves To a Promising Therapeutic Concept in Oncology
Current Medicinal Chemistry HtrA Serine Proteases as Potential Therapeutic Targets in Cancer
Current Cancer Drug Targets Dicoumarol: A Drug which Hits at Least Two Very Different Targets in Vitamin K Metabolism
Current Drug Targets The Prognostic Value of Cytokeratin and Extracellular Collagen Expression in Urinary Bladder Cancer
Current Molecular Medicine Discovery and Development of Natural Products and their Derivatives as Photosensitizers for Photodynamic Therapy
Current Medicinal Chemistry Cell Cycle and Cancer: The G1 Restriction Point and the G1 / S Transition
Current Genomics Human Galectin-1 in Multiple Cancers: A Privileged Molecular Target in Oncology
Mini-Reviews in Medicinal Chemistry Palifermin in theManagement of Mucositis in Hematological Malignancies: Current Evidences and Future Perspectives
Cardiovascular & Hematological Agents in Medicinal Chemistry Synthesis, Molecular Docking Study, and Cytotoxic Activity of 3,4-diaryl-5-(4-pyridinyl)-1,2,4-oxadiazole
Medicinal Chemistry Basic Approaches in Therapy of Multiple Sclerosis (MS) and Related Diseases: Current Achievement and Prospective
Central Nervous System Agents in Medicinal Chemistry Antisense Oligonucleotide Drug Design
Current Pharmaceutical Design Cell Death in Mammalian Development
Current Pharmaceutical Design Synthesis of Pyridine and Spiropyridine Derivatives Derived from 2-aminoprop- 1-ene-1,1,3-tricarbonitrile Together with their c-Met Kinase and Antiproliferative Evaluations
Anti-Cancer Agents in Medicinal Chemistry In Vitro Screening of an FDA-Approved Library Against ESKAPE Pathogens
Current Pharmaceutical Design Targeting Calcium Channels to Block Tumor Vascularization
Recent Patents on Anti-Cancer Drug Discovery MicroRNAs in Cancer Stem Cells: New Regulators of Stemness
Current Pharmaceutical Design Nuclear Architecture and Gene Expression in the Quest for Novel Therapeutics
Current Pharmaceutical Design 4-Anilinoquinazoline Derivatives with Epidermal Growth Factor Receptor Inhibitor Activity
Anti-Cancer Agents in Medicinal Chemistry Electrochemical Study of DNA Damaged by Oxidation Stress
Combinatorial Chemistry & High Throughput Screening